All terms in UBERON

Label Id Description
negative regulation of immunoglobulin mediated immune response GO_0002890 [Any process that stops, prevents, or reduces the frequency, rate, or extent of an immunoglobulin mediated immune response.]
negative regulation of B cell mediated immunity GO_0002713 [Any process that stops, prevents, or reduces the frequency, rate, or extent of B cell mediated immunity.]
high nuclear/cytoplasmic ratio PATO_0040072 [A quality inhering in a cell by virtue of the cell having a high nuclear/cytoplasmic ratio.]
cellular quality PATO_0001396 [A monadic quality of continuant that exists at the cellular level of organisation.]
nuclear chromosome GO_0000228 [A chromosome that encodes the nuclear genome and is found in the nucleus of a eukaryotic cell during the cell cycle phases when the nucleus is intact.]
chromosome GO_0005694 [A structure composed of a very long molecule of DNA and associated proteins (e.g. histones) that carries hereditary information.]
regulation of B cell mediated immunity GO_0002712 [Any process that modulates the frequency, rate, or extent of B cell mediated immunity.]
positive regulation of myeloid leukocyte mediated immunity GO_0002888 [Any process that activates or increases the frequency, rate, or extent of myeloid leukocyte mediated immunity.]
regulation of myeloid leukocyte mediated immunity GO_0002886 [Any process that modulates the frequency, rate, or extent of myeloid leukocyte mediated immunity.]
positive regulation of leukocyte mediated immunity GO_0002705 [Any process that activates or increases the frequency, rate, or extent of leukocyte mediated immunity.]
negative regulation of myeloid leukocyte mediated immunity GO_0002887 [Any process that stops, prevents, or reduces the frequency, rate, or extent of myeloid leukocyte mediated immunity.]
negative regulation of leukocyte mediated immunity GO_0002704 [Any process that stops, prevents, or reduces the frequency, rate, or extent of leukocyte mediated immunity.]
regulation of leukocyte mediated immunity GO_0002703 [Any process that modulates the frequency, rate, or extent of leukocyte mediated immunity.]
skeletal myofibril assembly GO_0014866 [The process whose specific outcome is the progression of the skeletal myofibril over time, from its formation to the mature structure. A skeletal myofibril is a myofibril specific to skeletal muscle cells.]
neurotransmitter secretion involved in regulation of skeletal muscle contraction GO_0014860 [The regulated release of neurotransmitter into the synaptic cleft involved in skeletal muscle contraction. A neurotransmitter is any of a group of substances that are released on excitation from the axon terminal of a presynaptic neuron of the central or peripheral nervous system and travel across the synaptic cleft to either excite or inhibit the target cell. Among the many substances that have the properties of a neurotransmitter are acetylcholine, noradrenaline, adrenaline, dopamine, glycine, gamma aminobutyrate, glutamic acid, substance P, enkephalins, endorphins and serotonin.]
regulation of skeletal muscle contraction via regulation of action potential GO_0014861 [Any process that modulates the frequency, rate or extent of skeletal muscle contraction by depolarization of muscle membrane and ionic fluxes.]
regulation of action potential GO_0098900 [Any process that modulates the frequency, rate or extent of action potential creation, propagation or termination. This typically occurs via modulation of the activity or expression of voltage-gated ion channels.]
regulation of skeletal muscle contraction GO_0014819 [Any process that modulates the frequency, rate or extent of skeletal muscle contraction.]
L-tyrosine import across plasma membrane GO_1903808 [The directed movement of L-tyrosine from outside of a cell, across the plasma membrane and into the cytosol.]
amino acid import across plasma membrane GO_0089718 [The directed movement of an amino acid from outside of a cell, across the plasma membrane and into the cytosol.]